GSK: Antibody treatment has potential to work against omicron

GlaxoSmithKline on Tuesday said that its COVID-19 antibody treatment had positive results in lab tests that show it has the potential to be effective against the new omicron variant.GSK, and its partner Vir Biotechnology, tested the antibody...